13F HOLDINGS REPORT
GREAT POINT PARTNERS LLC
Quarter ended Q2 2024 · Filed August 14, 2024 · Accession 0001172661-24-003577
Total Value
$522.0M
Positions
33
Other Managers
2
Confidential Omitted
No
Holdings (33)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | UROGEN PHARMA LTD | URGN | 2,906,259 | $48.8M | 9.34% |
| 2 | NEUROGENE INC | NGNE | 1,004,291 | $36.5M | 7.00% |
| 3 | ABIVAX SA | AAVXF | 2,472,188 | $32.7M | 6.26% |
| 4 | MERUS N V | N5749R100 | 523,288 | $31.0M | 5.93% |
| 5 | PLIANT THERAPEUTICS INC | PLRX | 2,636,864 | $28.3M | 5.43% |
| 6 | ARCELLX INC | ACLX | 492,000 | $27.2M | 5.20% |
| 7 | DYNAVAX TECHNOLOGIES CORP | 268158201 | 2,374,000 | $26.7M | 5.11% |
| 8 | EVOLUS INC | EOLS | 2,451,772 | $26.6M | 5.10% |
| 9 | CYTOKINETICS INC | CYTK | 474,202 | $25.7M | 4.92% |
| 10 | DIANTHUS THERAPEUTICS INC | DNTH | 757,929 | $19.6M | 3.76% |
| 11 | INSMED INC | INSM | 250,000 | $16.8M | 3.21% |
| 12 | ZURA BIO LTD | ZURA | 4,642,241 | $16.2M | 3.11% |
| 13 | KALVISTA PHARMACEUTICALS INC | KALV | 1,338,568 | $15.8M | 3.02% |
| 14 | IONIS PHARMACEUTICALS INC | IONS | 330,000 | $15.7M | 3.01% |
| 15 | CONTEXT THERAPEUTICS INC | CNTX | 7,419,355 | $14.9M | 2.85% |
| 16 | AMICUS THERAPEUTICS INC | FOLD | 1,495,500 | $14.8M | 2.84% |
| 17 | OPTINOSE INC | 68404V100 | 13,727,097 | $14.3M | 2.73% |
| 18 | ESPERION THERAPEUTICS INC NE | ESPR | 5,791,594 | $12.9M | 2.46% |
| 19 | VOYAGER THERAPEUTICS INC | VYGR | 1,601,527 | $12.7M | 2.43% |
| 20 | OUTLOOK THERAPEUTICS INC | OTLK | 1,701,510 | $12.6M | 2.41% |
| 21 | AUTOLUS THERAPEUTICS PLC | AUTL | 3,441,667 | $12.0M | 2.29% |
| 22 | JASPER THERAPEUTICS INC | JSPRW | 402,015 | $9.1M | 1.75% |
| 23 | OLEMA PHARMACEUTICALS INC | OLMA | 796,880 | $8.6M | 1.65% |
| 24 | TERNS PHARMACEUTICALS INC | TERN | 1,149,406 | $7.8M | 1.50% |
| 25 | VIRIDIAN THERAPEUTICS INC | VRDN | 500,000 | $6.5M | 1.25% |
| 26 | TSCAN THERAPEUTICS INC | TCRX | 940,831 | $5.5M | 1.05% |
| 27 | VISTAGEN THERAPEUTICS INC | VTGN | 1,529,338 | $5.3M | 1.02% |
| 28 | HELIX ACQUISITION CORP II | HLXC | 500,000 | $5.1M | 0.98% |
| 29 | PUMA BIOTECHNOLOGY INC | PBYI | 1,486,544 | $4.8M | 0.93% |
| 30 | KYVERNA THERAPEUTICS INC | KYTX | 499,152 | $3.7M | 0.72% |
| 31 | SPYRE THERAPEUTICS INC | SYRE | 134,612 | $3.2M | 0.61% |
| 32 | ANAPTYSBIO INC | ANABV | 25,000 | $626,500 | 0.12% |
| 33 | LEXICON PHARMACEUTICALS INC | LXRX | 30,000 | $50,400 | 0.01% |